Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma Chao YangHe ChengChen Liu Original Article 22 August 2018 Pages: 1815 - 1823
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC) Sabine SchmidStefan DiemMartin Früh Original Article 31 August 2018 Pages: 1825 - 1832
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies Allison S. DobryCheryl K. ZoggJ. Bryan Iorgulescu Original Article 06 September 2018 Pages: 1833 - 1844
Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy Henning ZelbaJonas BochemBenjamin Weide Original Article 14 September 2018 Pages: 1845 - 1851
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma Jhanelle E. GrayAlberto ChiapporiScott J. Antonia Clinical Trial Report Open access 12 September 2018 Pages: 1853 - 1862
Cancer vaccine strategies: translation from mice to human clinical trials Jay A. BerzofskyMasaki TerabeLauren V. Wood Focussed Research Review 15 November 2017 Pages: 1863 - 1869
Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints Avishai ShemeshMichael BrusilovskyAngel Porgador Focussed Research Review 20 December 2017 Pages: 1871 - 1883
Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe? S. M. Mansour HaeryfarChristopher R. ShalerPatrick T. Rudak Focussed Research Review 22 February 2018 Pages: 1885 - 1896
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer Daniel Rojas-SepúlvedaAndrés TittarelliFlavio Salazar-Onfray Focussed Research Review Open access 29 March 2018 Pages: 1897 - 1910
Personalized cancer vaccines: adjuvants are important, too Cécile GouttefangeasHans-Georg Rammensee Focussed Research Review 11 April 2018 Pages: 1911 - 1918
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment Katerina PilatovaBeatrix BencsikovaLenka Zdrazilova-Dubska Focussed Research Review 10 May 2018 Pages: 1919 - 1929
Cystatin F as a regulator of immune cell cytotoxicity Janko KosMilica Perišić NanutAnahid Jewett Focussed Research Review 10 May 2018 Pages: 1931 - 1938
Dendritic cell trafficking in tumor-bearing mice Sarah C. KrzastekEkaterine GoliadzeGeorgi Guruli Focussed Research Review 25 June 2018 Pages: 1939 - 1947
The role of CCR5 in directing the mobilization and biological function of CD11b+Gr1+Ly6Clow polymorphonuclear myeloid cells in cancer Nathan KarinHila Razon Focussed Research Review 19 September 2018 Pages: 1949 - 1953
Targeting CTCFL/BORIS for the immunotherapy of cancer Dmitri Loukinov Focussed Research Review 02 November 2018 Pages: 1955 - 1965